Healio2 小时
Automated insulin delivery provides range of glycemic benefits in type 2 diabetes
Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...
Modern Healthcare2 小时
FDA deems Medtronic’s Pipeline Vantage recall ‘most serious’
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
MedPage Today3 小时
CDC Division in Jeopardy; RFK Jr. Silent on Mercury; What Works for Low Back Pain?
HHS Secretary Robert F. Kennedy Jr., who once discovered dangerous levels of mercury in his blood, remained silent as the ...
FDA tags Medtronic embolisation device recall as Class I
Medtronic initiated the recall of certain Pipeline Vantage embolisation devices in January 2025 following reports of four ...
Medtronic recalls embolization devices tied to 17 injuries, 4 deaths
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
Medtronic slips after FDA notice on product recall (update)
Medtronic (MDT) stock turned lower as the FDA announced a most serious type of recall involving its Pipeline Vantage 027 ...
FDA classifies recall of Medtronic embolization devices as 'most serious'
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
FDA issues Medtronic embolization device recall and correction notice
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
MedTech Dive1 天
Top device firms report safety data late: BMJ
BD, Medtronic and Abbott were among the top 10 medical device manufacturers with the highest number of late reports, the ...
Scientific American1 天
New Form of Parkinson’s Treatment Uses Real-Time Deep-Brain Stimulation
Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...
The Manila Times1 天
AI in Remote Patient Monitoring Market worth US$8,438.5 million by 2030 with 27.5% CAGR ...
The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million in 2023, is forecasted to grow at a robust CAGR of 27.5%, reaching US$1967.7 million in 2024 and an impressive US$8438.5 ...